Cyclopropanes Concept

Vocabulary Service

MeSH

Overview

subject area of

Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy Journal Articles
An evaluation of roflumilast and PDE4 inhibitors with a focus on the treatment of asthma Journal Articles
Attenuation of the September Epidemic of Asthma Exacerbations in Children: A Randomized, Controlled Trial of Montelukast Added to Usual Therapy Journal Articles
Can Montelukast Shorten Prednisolone Therapy in Children with Mild to Moderate Acute Asthma? A Randomized Controlled Trial Journal Articles
Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis Journal Articles
Cyclopropane fatty acyl synthase in Sinorhizobium meliloti Journal Articles
Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials Journal Articles
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals Journal Articles
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals Journal Articles
Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease Journal Articles
Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β₂-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE²SPOND). A Randomized Clinical Trial Journal Articles
Effects of Montelukast and Budesonide on Airway Responses and Airway Inflammation in Asthma Journal Articles
Effects of a cysteinyl leukotriene receptor antagonist on eosinophil recruitment in experimental allergic rhinitis Journal Articles
Effects of montelukast and budesonide on airway responses and airway inflammation in asthma Journal Articles
Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β<sub>2</sub>-agonist fixed-dose combination: RE<sup>2</sup>SPOND rationale and study design Journal Articles
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials Journal Articles
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study Journal Articles
Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma Journal Articles
Fibroblast growth factor 23: associations with antiretroviral therapy in patients co‐infected with HIV and hepatitis C Journal Articles
Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs Journal Articles
Melatonin agonists in primary insomnia and depression-associated insomnia: Are they superior to sedative-hypnotics? Journal Articles
Montelukast Treatment Attenuates the Increase in Myofibroblasts Following Low-Dose Allergen Challenge Journal Articles
Montelukast and Churg-Strauss syndrome Journal Articles
Montelukast as Add-On Therapy to Inhaled Corticosteroids in the Management of Asthma (The SAS Trial) Journal Articles
Montelukast as Add-On Therapy with Inhaled Corticosteroids Alone or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (the RADAR Trial) Journal Articles
Montelukast as an Alternative to Low-Dose Inhaled Corticosteroids in the Management of Mild Asthma (The SIMPLE Trial): An Open-Label Effectiveness Trial Journal Articles
Montelukast for the treatment of asthma in the adult population Journal Articles
Montelukast in childhood asthma: what is the evidence for its use? Journal Articles
Pharmacogenetic-Based Efavirenz Dose Modification: Suggestions for an African Population and the Different CYP2B6 Genotypes Journal Articles
Pharmacology of montelukast sodium (Singulair™), a potent and selective leukotriene D₄ receptor antagonist Journal Articles
Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement Journal Articles
Phosphodiesterase-4 inhibition in COPD Journal Articles
Potentiation of long-acting β2-agonist and glucocorticoid responses in human airway epithelial cells by modulation of intracellular cAMP Journal Articles
Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis Journal Articles
Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects Journal Articles
Roflumilast for asthma: Efficacy findings in mechanism of action studies Journal Articles
Roflumilast for asthma: Efficacy findings in non-placebo-controlled comparator and dosing studies Journal Articles
Roflumilast for asthma: Weighing the evidence Journal Articles
Role of Leukotrienes and Leukotriene Receptor Antagonists in Asthma Journal Articles
Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts Journal Articles
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry Journal Articles
Single-dose desloratadine and montelukast and allergen-induced late airway responses Journal Articles
The Back to School asthma study: the effect of montelukast on asthma burden when initiated prophylactically at the start of the school year Journal Articles
The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects Journal Articles
The effect of montelukast, budesonide alone, and in combination on exercise-induced bronchoconstriction Journal Articles
The effects of montelukast on tissue inflammatory and bone marrow responses in murine experimental allergic rhinitis: interaction with interleukin‐5 deficiency Journal Articles
Therapy with Efavirenz plus Indinavir in Patients with Extensive Prior Nucleoside Reverse‐Transcriptase Inhibitor Experience: A Randomized, Double‐Blind, Placebo‐Controlled Trial Journal Articles